Zhengye Biotechnology Holding (ZYBT) Total Current Liabilities (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has 3 years of Total Current Liabilities data on file, last reported at $17.0 million in Q4 2025.

• Total Current Liabilities for Q4 2025 came in at $17.0 million, down 10.22% year-over-year; the trailing twelve-month figure through Dec 2025 was $17.0 million (down 10.22% YoY), and the FY2025 annual result was $17.2 million, down 7.46% from the prior year.
• Total Current Liabilities fell to $17.0 million in Q4 2025 per ZYBT's latest filing, from $18.8 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $20.9 million in Q4 2023 and troughed at $17.0 million in Q4 2025.
• A 3-year average of $18.9 million and a median of $18.9 million in 2024 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2024 and 2025: Total Current Liabilities slipped 9.32% in 2024, then dropped 10.22% in 2025.
• A 3-year view of Total Current Liabilities shows it stood at $20.9 million in 2023, then fell by 9.32% to $18.9 million in 2024, then retreated by 10.22% to $17.0 million in 2025.
• Business Quant data shows ZYBT's Total Current Liabilities at $17.0 million in Q4 2025, $18.8 million in Q2 2025, and $18.9 million in Q4 2024.